Chemical Formula: C30H42O7
Chemical Formula C30H42O7
Found 204 metabolite its formula value is C30H42O7
elatericin B
Cucurbitacin I is a cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene substituted by hydroxy groups at positions 2, 16, 20 and 25 and oxo groups at positions 1, 11 and 22. It has a role as a plant metabolite and an antineoplastic agent. It is a cucurbitacin and a tertiary alpha-hydroxy ketone. Cucurbitacin I is a natural product found in Elaeocarpus chinensis, Elaeocarpus hainanensis, and other organisms with data available. A cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene substituted by hydroxy groups at positions 2, 16, 20 and 25 and oxo groups at positions 1, 11 and 22. Cucurbitacin I is a natural selective inhibitor of JAK2/STAT3, with potent anti-cancer activity.
stigmatellin
A member of the class of chromones that is isolated from Stigmatella aurantiaca Sg a15. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
Ganoderic acid J
Ganoderic acid J is found in mushrooms. Ganoderic acid J is a metabolite of Ganoderma lucidum (reishi).
Ganoderenic acid B
Ganoderenic acid B is found in mushrooms. Ganoderenic acid B is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderenic acid B is found in mushrooms. Ganoderenic acid B is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderenic acid B exhibits potent reversal effect on ABCB1-mediated multidrug resistance of HepG2/ADM cells to Doxorubicin[1].
Ganoderic acid C1
Ganoderic acid C1 is found in mushrooms. Ganoderic acid C1 is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid C1 is found in mushrooms. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Ganoderenic acid A
Ganoderenic acid A is found in mushrooms. Ganoderenic acid A is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderenic acid A is found in mushrooms. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1]. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1].
Ganoderic acid xi
Ganoderic acid xi is found in mushrooms. Ganoderic acid xi is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid xi is found in mushrooms.
Ganoderic acid V1
Ganoderic acid V1 is found in mushrooms. Ganoderic acid V1 is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Ganoderic acid V1 is found in mushrooms.
Ganosporelactone B
Ganosporelactone B is found in mushrooms. Ganosporelactone B is isolated from the spores of Ganoderma lucidum (reishi).
Cucurbitacin I
Ganoderic acid D
Ganoderic acid C1 is a triterpenoid. Ganoderic acid C1 is a natural product found in Ganoderma lucidum with data available. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Laulimalide
A macrolide with formula C30H42O7 that is isolated from the marine sponges, Cacospongia mycofijiensis and Hyattella sp.
Ganoderic acid D
Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Anhydrocochlioquinone A
[Raw Data] CBA28_Anhydrocochlioq_pos_50eV_1-2_01_1556.txt [Raw Data] CBA28_Anhydrocochlioq_pos_40eV_1-2_01_1555.txt [Raw Data] CBA28_Anhydrocochlioq_pos_30eV_1-2_01_1554.txt [Raw Data] CBA28_Anhydrocochlioq_pos_20eV_1-2_01_1553.txt [Raw Data] CBA28_Anhydrocochlioq_pos_10eV_1-2_01_1541.txt
(17R,20S,22R)-4beta-hydroxy-1-oxo-5beta,6beta-epoxy-16alpha-acetoxywitha-2-enolide
3beta-O-(beta-D-sarmentosyl)-8,14-epoxy-5beta,14beta-card-16,20(22)-dienolide|cardenolide N-2
Cucurbitacin I
Cucurbitacin i is a member of the class of compounds known as cucurbitacins. Cucurbitacins are polycyclic compounds containing the tetracyclic cucurbitane nucleus skeleton, 19-(10->9b)-abeo-10alanost-5-ene (also known as 9b-methyl-19-nor lanosta-5-ene), with a variety of oxygenation functionalities at different positions. Cucurbitacin i is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cucurbitacin i can be found in cucumber, which makes cucurbitacin i a potential biomarker for the consumption of this food product. Cucurbitacin I is a natural selective inhibitor of JAK2/STAT3, with potent anti-cancer activity.
7??,23?鈥?Dihydroxy-3,11,15-trioxolanosta-8,20E(22)-dien-26-oic acid
methyl 7beta-hydroxy-3,11,15,23-tetraoxo-5alpha-lanost-8-en-26-oate
(5alpha,6beta,18S,22R)-18,20-epoxy-6,22-dihydroxy-5,18-dimethoxy-1-oxoergosta-2,24-dien-26-oic acid delta-lactone|5-O-methoxywithaphysalin R
3,7,11,15,23-pentaoxolanostan-26-oic acid|8beta,9alpha-dihydroganoderic acid C
(17R,20S,22R)-4beta-hydroxy-1-oxo-5beta,6beta-epoxy-18-acetoxywitha-2-enolide
12-O-tiglyl-4-deoxy-4alpha-phorbol-13-(2-methyl)butyrate
3beta(H)-1-oxo-7beta,9alpha,13-triangelyloxylongipinane
eudesm-11-en-4alpha-O-beta-D-2-cinnamoyloxy-glucopyranoside|fissipallin
(3beta,5beta,6beta,18S,22R)-5,6:18,20-diepoxy-22-hydroxy-3,18-dimethoxy-1-oxoergost-24-en-26-oic acid delta-lactone|withaphysalin Q
(4aR)-9-((1S)-2cF-Acetoxy-1rF,3tF-dimethyl-pent-catF-yl)-3t-(alpha-hydroxy-isopropyl)-6a,12b-dimethyl-(4ar,6at,12bt)-1,2,3,4a,5,6,6a,12b-octahydro-pyrano[3,2-a]xanthen-8,11-dion|(4aR)-9-((1S)-2cF-acetoxy-1rF,3tF-dimethyl-pent-catF-yl)-3t-(alpha-hydroxy-isopropyl)-6a,12b-dimethyl-(4ar,6at,12bt)-1,2,3,4a,5,6,6a,12b-octahydro-pyrano[3,2-a]xanthene-8,11-dione|anhydroisocochlioquinone A
Ganoderic acid LM2
Ganoderenic acid B
Ganoderenic acid B is a triterpenoid. CID 78074039 is a natural product found in Ganoderma applanatum and Ganoderma lucidum with data available. Ganoderenic acid B is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderenic acid B exhibits potent reversal effect on ABCB1-mediated multidrug resistance of HepG2/ADM cells to Doxorubicin[1].
Ganoderenic acid A
Ganoderenic acid A is a triterpenoid. (E)-6-[(7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid is a natural product found in Ganoderma applanatum and Ganoderma lucidum with data available. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1]. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1].
Ganoderic acid J
Ganoderic acid C
Ganoderic acid Z
Ganosporelactone B
Ganoderic acid V1
17-[(E)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthrene-3,11-dione
(Z)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid
(8S,9R,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthrene-3,11-dione
15-[1-(4,5-dimethyl-6-oxooxan-2-yl)ethyl]-6-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-14-yl acetate
(2r,5z)-6-[(1s,3as,4r,5as,7r,9ar,11as)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
(2z)-6-[(1r,3s,3ar,4s,5ar,9as,11ar)-3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-2-methylhepta-2,6-dienoic acid
(2s,5e)-6-[(1r,3ar,4s,5ar,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
(2r,6s)-6-[(1r,3ar,4s,5ar,9as,11ar)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
2-[(3r,4s,5s,6s,7e,9e,11e)-4,6-dimethoxy-3,5,11-trimethyltrideca-7,9,11-trien-1-yl]-8-hydroxy-5,7-dimethoxy-3-methylchromen-4-one
(2r,6r)-6-[(1r,3as,3br,5ar,9as,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-octahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
3,4-dihydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-2,3,4,5,5a,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-5'',7,10-trione
5'-(1-{1-ethyl-5,6,6-trimethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-6',10'-dimethyl-13'-oxaspiro[oxolane-2,11'-tetracyclo[7.5.0.0²,⁶.0¹²,¹⁴]tetradecan]-8'-ene-5,7'-dione
(6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
6-{4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxohept-5-enoic acid
6-{3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-octahydro-1h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxoheptanoic acid
(1r,3e,5r,7s,9r,10e,12s,13s,14r)-1-(acetyloxy)-13-hydroxy-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-9-yl (2e)-3-[(2s,3r)-3-propyloxiran-2-yl]prop-2-enoate
(3s,3as,6r,7ar)-5-{5-[(5r,6s,7as)-6-ethenyl-3-(hydroxymethyl)-6-methyl-2-oxo-4,5,7,7a-tetrahydro-1-benzofuran-5-yl]hex-5-en-2-yl}-6-ethyl-3-hydroxy-3-(hydroxymethyl)-6-methyl-7,7a-dihydro-3ah-1-benzofuran-2-one
7-hydroxy-12-[1-hydroxy-3-(4-methyl-3,6-dihydro-2h-pyran-2-yl)prop-2-en-1-yl]-3-methyl-5-methylidene-9,13,22-trioxatricyclo[16.3.1.0⁸,¹⁰]docosa-15,19-dien-14-one
15-(1-{2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl}ethyl)-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-14-yl acetate
(2s,3s,4s)-2-[(2r,4ar,10ar,12ar)-2-(2-hydroxypropan-2-yl)-4a,10a-dimethyl-6,9-dioxo-2,3,4,11,12,12a-hexahydro-1,10-dioxatetraphen-8-yl]-4-methylhexan-3-yl acetate
4,4',6,12,17,17-hexamethyl-9,18,23,24-tetraoxaspiro[hexacyclo[20.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰.0¹⁶,²²]pentacosane-8,2'-oxolan]-20-ene-5',19-dione
7β,23ξ-dihydroxy-3,11,15-trioxolanosta-8,-20e(22)-dien-26-oicacid
{"Ingredient_id": "HBIN013082","Ingredient_name": "7\u03b2,23\u03be-dihydroxy-3,11,15-trioxolanosta-8,-20e(22)-dien-26-oicacid","Alias": "NA","Ingredient_formula": "C30H42O7","Ingredient_Smile": "CC(CC(C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6167","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}